TBIQYR4359-Global Human Milk Oligosaccharides (HMO) Market Research Report 2019
- TBI985536
- February 08, 2019
- Global
- 93 pages
- QY Market Research
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.
The global Human Milk Oligosaccharides (HMO) market is valued at 110 million US$ in 2018 is expected to reach 720 million US$ by the end of 2025, growing at a CAGR of 27.0% during 2019-2025.
This report focuses on Human Milk Oligosaccharides (HMO) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Milk Oligosaccharides (HMO) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Abbott
Inbiose
Company two
Jennewein Biotechnologie
Glycom
ZuChem
Dextra Laboratories
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Neutral
Acidic
Segment by Application
Food Industry
Laboratory Research
Table of Contents
Executive Summary
1 Human Milk Oligosaccharides (HMO) Market Overview
1.1 Product Overview and Scope of Human Milk Oligosaccharides (HMO)
1.2 Human Milk Oligosaccharides (HMO) Segment by Type
1.2.1 Global Human Milk Oligosaccharides (HMO) Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Neutral
1.2.3 Acidic
1.3 Human Milk Oligosaccharides (HMO) Segment by Application
1.3.1 Human Milk Oligosaccharides (HMO) Consumption Comparison by Application (2014-2025)
1.3.2 Food Industry
1.3.3 Laboratory Research
1.3 Global Human Milk Oligosaccharides (HMO) Market by Region
1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Human Milk Oligosaccharides (HMO) Market Size
1.4.1 Global Human Milk Oligosaccharides (HMO) Revenue (2014-2025)
1.4.2 Global Human Milk Oligosaccharides (HMO) Production (2014-2025)
2 Global Human Milk Oligosaccharides (HMO) Market Competition by Manufacturers
2.1 Global Human Milk Oligosaccharides (HMO) Production Market Share by Manufacturers (2014-2019)
2.2 Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers (2014-2019)
2.3 Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Human Milk Oligosaccharides (HMO) Production Sites, Area Served, Product Types
2.5 Human Milk Oligosaccharides (HMO) Market Competitive Situation and Trends
2.5.1 Human Milk Oligosaccharides (HMO) Market Concentration Rate
2.5.2 Human Milk Oligosaccharides (HMO) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Human Milk Oligosaccharides (HMO) Production Market Share by Regions
3.1 Global Human Milk Oligosaccharides (HMO) Production Market Share by Regions
3.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Regions (2014-2019)
3.3 Global Human Milk Oligosaccharides (HMO) Production, Revenue, Price and Gross ...
| read more...
